ITCH

Dermatology·MeSH: Dermatitis, Atopic

17 drugs in development·11 companies·1 clinical trial

Drug Pipeline by Phase

Approved(15)

Drug	Company
astepro	Viatris Inc (VTRS)
butenafine	SUNSET ISLAND GROUP (SUN)
cetirizine hydrochloride allergy	PERRIGO Co plc (PRGO)
children's cetirizine hydrochloride hives relief	TESARO, Inc. (TSRO)
fexofenadine	DR REDDYS LABORATORIES LTD (RDY)
fexofenadine	PERRIGO Co plc (PRGO)
lamisil	Novartis AG (NVS)
levothyroxine	MAIA Biotechnology, Inc. (MAIA)
loratadine	PERRIGO Co plc (PRGO)
loratadine redidose	SUNSET ISLAND GROUP (SUN)
nasonex 24hr allergy	PERRIGO Co plc (PRGO)
terbinafine	SUNSET ISLAND GROUP (SUN)
triamcinolone acetonide	Aptinyx Inc. (APTX)
triamcinolone acetonide	PERRIGO Co plc (PRGO)
zerviate	HARROW, INC. (IMMY)

Preclinical(1)

Drug	Company
Anti-itch Product	Journey Medical Corp (DERM)

Unknown(1)

Drug	Company
Oral C5 Inhibitor	BIOCRYST PHARMACEUTICALS INC (BCRX)

BioSniper tracks 17 drugs in development for ITCH across 11 companies.

There are 1 clinical trial targeting ITCH tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.